BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7997759)

  • 1. [Counterimmunoelectrophoresis technique for determining the antigenic potency of rabies vaccine].
    Miceli G; Torroba JE; Diaz AM
    Rev Inst Med Trop Sao Paulo; 1993; 35(6):543-50. PubMed ID: 7997759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the single radial immunodiffusion test as a replacement for the NIH mouse potency test for rabies vaccine.
    Fitzgerald EA; Needy CF
    Dev Biol Stand; 1986; 64():73-9. PubMed ID: 3098606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Potency testing of inactivated rabies vaccines with the antibody binding test in comparison with the NIH and habel test(author's transl)].
    Oei HL; Krauss H
    Zentralbl Bakteriol Orig A; 1975; 231(1-3):1-14. PubMed ID: 1154901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of inactivated rabies vaccine for human use on WI38 diploid cells. Results of potency tests. Stability of the vaccine in liquid and freeze-dried forms.
    Nicolas AJ; Patet J; Falquet JC; Branche R; Delaiti P; Montagnon B; Peyron L; Soulebot JP
    Dev Biol Stand; 1978; 40():17-24. PubMed ID: 680392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the antibody assay in immunized mice for the determination of rabies vaccine potency.
    Fitzgerald EA; Gallagher M; Hunter WS; Seligmann EB
    Dev Biol Stand; 1978; 40():183-6. PubMed ID: 355013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines.
    Rooijakkers E; Groen J; Uittenbogarrd J; van Herwijnen J; Osterhaus A
    Dev Biol Stand; 1996; 86():137-45. PubMed ID: 8785943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single radial immunodiffusion assays for the standardization of the antigenic content of rabies vaccines.
    Ferguson M; Seagroatt V; Schild GC
    Dev Biol Stand; 1986; 64():81-6. PubMed ID: 3098607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison studies on potency tests for rabies vaccines.
    Wiktor TJ; Atanasiu P; Bahmanyar M; Boegel K; Cox JH; Diaz AM; Fitzgerald EA; Kuwert E; Netter R; Selimov M; Turner G; van Steenis G
    Dev Biol Stand; 1978; 40():171-8. PubMed ID: 355011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potency testing of diploid-cell rabies vaccine and correlation with immunogenicity.
    Tint H; Rosanoff EI
    Dev Biol Stand; 1978; 40():195-201. PubMed ID: 680393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardization of an enzyme immunoassay for the in vitro potency assay of inactivated tissue culture rabies vaccines: determination of the rabies virus glycoprotein with polyclonal antisera.
    Thraenhart O; Ramakrishnan K
    J Biol Stand; 1989 Oct; 17(4):291-309. PubMed ID: 2613705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency evaluation of rabies vaccine for human use: the impact of the reduction in the number of animals per dilution.
    de Moura WC; de Araujo HP; Cabello PH; Romijn PC; Leite JP
    J Virol Methods; 2009 Jun; 158(1-2):84-92. PubMed ID: 19428574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the usefulness of the peripheral test for determination of rabies vaccine potency].
    Wysokińska T; Janaszek W; Rymkiewicz D; Słowikowska M
    Med Dosw Mikrobiol; 1996; 48(3-4):211-3. PubMed ID: 9182144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro potency tests: challenges encountered during method development.
    Yomayuza CL; Thiel HJ; König M
    Dev Biol (Basel); 2012; 134():93-100. PubMed ID: 22888600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The rabies peripheral challenge test: more accurate determination of vaccine potency.
    Wunderli PS; Dreesen DW; Miller TJ; Baer GM
    Vaccine; 2006 Nov; 24(49-50):7115-23. PubMed ID: 16919854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative determination of rabies antigen by ELISA.
    van der Marel P; van Wezel AL
    Dev Biol Stand; 1981; 50():267-75. PubMed ID: 7341294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antirabies vaccine from the brain of the suckling rat: antigen composition and immunogenic capacity].
    Díaz AM; Dellepiane N; Palomo LF
    Bol Oficina Sanit Panam; 1989 Sep; 107(3):185-95. PubMed ID: 2532895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potency test which simulates natural exposure for measuring post-exposure activity of rabies vaccines. A proposal for preparing a relevant international reference preparation.
    Bijlenga G
    Dev Biol Stand; 1978; 40():203-8. PubMed ID: 567153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardization of methods used for testing the safety of tissue culture rabies vaccines.
    Romanova LN; Polyushkina GS
    Dev Biol Stand; 1978; 40():209-13. PubMed ID: 680394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thermostability of rabies vaccine, type Fuenzalida & Palacios, for human use].
    Albas A; Fuches RM; Gallina NM; Mendonça RM; Fang FL; Valentini EJ
    Rev Inst Med Trop Sao Paulo; 1992; 34(1):27-31. PubMed ID: 1284895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of various immunochemical, biochemical and biological methods for the analysis of rabies virus production in tissue cultures.
    Adamovicz P; Aguilon F; David A; Le Fur R; Mazert MC; Perrin P; Reculard P; Sureau P
    Dev Biol Stand; 1983; 55():191-7. PubMed ID: 6677532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.